You are here

  • Home
  • Archive
  • Volume 95, Issue 3
  • One-year outcome of bilateral randomised prospective clinical trial comparing photorefractive keratectomy (PRK) with mitomycin C (MMC) and laser in situ keratomileusis (LASIK)

Article Text

Article menu
Download PDFPDF
PostScript
Letter
One-year outcome of bilateral randomised prospective clinical trial comparing photorefractive keratectomy (PRK) with mitomycin C (MMC) and laser in situ keratomileusis (LASIK)
  1. Merle Fernandes,
  2. Phaneendra Reddy,
  3. Sushmita G Shah
  1. LV Prasad Eye Institute, Anhdra Pradesh, India
  1. Correspondence to Dr Merle Fernandes, LV Prasad Eye Institute, GMRV Campus, Plot 87/2, Hanumanthawaka Junction, Visakhapatnam, Anhdra Pradesh, India; merle{at}lvpei.org

https://doi.org/10.1136/bjo.2010.188151

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We read with great interest the article by Wallau and Campos,1 who compared the 1-year outcome of photorefractive keratectomy (PRK) with mitomycin C (MMC) and laser in situ keratomileusis (LASIK) in a bilateral randomised prospective clinical trial. The authors concluded that Wavefront-guided PRK with 0.002% MMC is more effective than wavefront-guided LASIK for correction of moderate myopia, which is consistent with previous studies.2

    We would like to make the following comments.

    The authors have conducted a bilateral randomised control trial; however, …

    View Full Text

    Footnotes

    • Competing interests None.

    • Provenance and peer review Not commissioned; not externally peer reviewed.